Evgen Pharma (GB:TCF) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
TheraCryf plc, specializing in oncology and neuropsychiatry drug development, will release its interim results for the first half of 2024 on November 28. The company, which trades on AIM under the ticker TCF, invites current and potential investors to a live presentation on the same day, providing an opportunity for engagement and questions.
For further insights into GB:TCF stock, check out TipRanks’ Stock Analysis page.
